Penn Medicine researchers were recently awarded a $14 million grant to launch Penn Innovation in Suicide Prevention Implementation Research.

Researchers found that Black, Hispanic, and American Indian/Alaska Native patients were less likely to receive newer and more effective — and now standard-of-care — blood thinners.

According to the most recent Food and Drug Administration data on clinical trial participation, close to 80% of people taking part in the United States are white.

During the walkout, over 3,000 Philadelphia students protested racial injustice within the education system.